Help from the following companies allows the Foundation to continue to expand the programs that support family physicians and the patients they serve.
Meet Our Partners
Pinnacle Level
The mission of the American Academy of Family Physicians is to promote improved health of the American people; to advance the specialty of family medicine through education, advocacy and communication; and to serve the unique needs of members with professionalism and creativity.
Originally founded in 1980 as AMGen (Applied Molecular Genetics), Amgen pioneered the development of novel and innovative products based on advances in recombinant DNA and molecular biology. More than a decade ago, Amgen introduced two of the first biologically-derived human therapeutics, EPOGEN® (Epoetin alfa) and NEUPOGEN® (Filgrastim), which became the biotechnology industry's first blockbusters.
AstraZeneca is one of the world's leading pharmaceutical companies. Backed by a strong research base and extensive manufacturing and commercial skills, we provide innovative, effective medicines that make a real difference for patients in important areas of health care.
Lilly, a leading innovation-driven corporation is developing a growing portfolio of pharmaceutical products by applying the latest research from its worldwide laboratories and partnerships with eminent scientific organizations. Through medicines and information, Lilly strives to provide answers for the world's medical needs. For more information, visit Lilly or Lilly For Better Health.
Purdue Pharma L.P. is one of the fastest-growing pharmaceutical companies in the world today. Our company and associated companies are led by physicians and scientists who recognize the importance of pain management. We have led the battle against inadequate treatment of pain by developing long-acting pain control medications that are prescribed by health care professionals around the world.
President’s Circle Level
For more than a century, Abbott has been working to advance health care for people around the world. Founded in 1988, Abbott has evolved into a diversified health care company that discovers, manufactures, and markets innovative products and services spanning the continuum of care from prevention and diagnosis and treatment and care.
Boehringer Ingelheim Pharmaceuticals, Inc., the US subsidiary of Boehringer Ingelheim, headquartered in Germany, operates globally in 47 countries with approximately 41,300 employees. The company is committed to researching, developing, manufacturing and marketing novel products of high therapeutic value for human and veterinary medicine. 
Bristol-Myers Squibb is a global research-based pharmaceutical and related health care products company whose mission is to extend and enhance human life. It is a leading provider of innovative therapies to treat cancer, cardiovascular and metabolic diseases, HIV/AIDS and other infectious diseases, and disorders of the central nervous system.
Endo Pharmaceuticals is a specialty pharmaceutical company with an established leadership in pain management. We research, develop and market prescription pharmaceuticals used primarily to treat and manage pain and are expanding our presence in complementary areas.
Forest Laboratories develops, manufactures and sells both branded and generic forms of ethical products that require a physician's prescription, as well as nonprescription pharmaceutical products sold over-the-counter that are used for the treatment of a wide range of illnesses.
Our mission is to improve the quality of human life by enabling people to do more, feel better and live longer. We are the only pharmaceutical company tackling the WHO's three 'priority' diseases: HIV/AIDS, tuberculosis and malaria. In addition to researching medicines in major diseases like cancer, we are also a leader in vaccines.
McNeil Pediatrics™, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc., markets CONCERTA® for the treatment of children, adolescents and adults with ADHD in the United States. McNeil Pediatrics continues to explore other new therapies to meet the needs of children and the pediatric community. Visit McNeil Pediatrics™ for more information.
MedImmune strives to provide better medicines to patients, new medical options for physicians and rewarding careers to employees. At MedImmune, we are actively engaged with community-based organizations. We seek to establish true relationships with the organizations we support and to contribute meaningfully to the communities in which our employees work and live. We look for associations with causes that are aligned with our areas of therapeutic focus and with the goal of advancing health and science education. We initiate programs, engage our approximately 3,000 employees worldwide in volunteer activities, and share our expertise to drive initiatives on a personal level. Headquartered in Maryland, MedImmune is wholly owned by AstraZeneca plc (LSE: AZN.L, NYSE: AZN).
Merck/Schering-Plough Pharmaceuticals is a joint venture between Merck & Co., Inc. and Schering-Plough Corporation formed to develop and market in the United States new prescription medicines in cholesterol management. The collaboration was expanded to include worldwide markets (excluding Japan).
Novo Nordisk is a global health care company with an 86-year history of innovation and achievement in diabetes care. Novo Nordisk is the only company in the US offering a comprehensive portfolio of insulin analogs and offers easy to use insulin delivery systems. In addition to diabetes care, Novo Nordisk has a leading position within areas such as hemostasis management, growth hormone therapy, and hormone therapy for women.
Pfizer Inc. discovers, develops, manufactures and markets leading prescription medicines for humans and animals, and many of the world's best-known consumer brands. Our innovative, value-added products improve the quality of life of people around the world and help them enjoy longer, healthier and more productive lives.
The Pharmaceutical Research and Manufacturers of America (PhRMA) represents the country’s leading pharmaceutical research and biotechnology companies, which are devoted to inventing medicines that allow patients to live longer, healthier, and more productive lives. PhRMA companies are leading the way in the search for new cures. PhRMA members alone invested an estimated $44.5 billion in 2007 in discovering and developing new medicines. Industry-wide research and investment reached a record $58.8 billion in 2007.
Roche is the U.S. pharmaceuticals headquarters of the Roche Group, one of the world’s leading research-oriented healthcare groups with core businesses in pharmaceuticals and diagnostics. For more than 100 years in the U.S., Roche addresses prevention, diagnosis and treatment of diseases, thus enhancing people's health and quality of life.
Grand Patron Level
Patron Level
- Coca-Cola North America
- Daiichi Sankyo
- Sage Software Healthcare
- Welch Allyn, Inc.
- Wyeth Pharmaceuticals
Sustaining Level
- Allergan
- Answers Media
- California Academy of Family Physicians
- Campbell Soup Company
- CECity.com, Inc.
- Chlorine Chemistry Division
- Conceptus Incorporated
- Covidien
- The Dow Chemical Company
- Ethicon Women's Health and Urology
- McDonald's Corporation
- McKesson
- MinuteClinic
- National Cattlemen's Beef Association
- Nestle USA, Inc., Nutrition Division
- Nordic Naturals
- PepsiCo
- Quantum Health, LLC
- Weight Watchers Foundation
- Wyeth Consumer Healthcare
Friends of the Foundation Level
- American Family Physician
- C. Duryee Consulting, LLC
- California Table Grape Commission
- Cerner Corporation
- Cultural Horizons
- Genova Diagnostics
- iMedica Corporation
- Promise
Corporate Partners
WHY DONATE TO THE AAFP FOUNDATION?
Supporting your Foundation means you believe in the power of family medicine and in the importance of helping others.
“Family Medicine has been great to me. It’s been good to my family. And I feel like it’s now time for me to give back.” - William H. Coleman, MD, PhD
